26th June 2020
Update: Q4 Results FY'20 Glenmark Pharmaceuticals Limited (GPL) - a research-led global integrated pharmaceutical company, on Friday announced its financial results for the 4th quarter and year ended March 31, 2020. The company's consolidated revenue for the quarter rose 7.96% to INR 2,767.48 Cr as against INR 2,563.47 Cr a year ago. The Company posted a 36.28% rise in its consolidated net profit to INR 220.3 Cr for the 4th quarter ended March 31, 2020. The drug firm had reported a net
